Enhancing Oncology analysis with built-in KRAS Assay providers and RAS Assays
In the quickly evolving industry of oncology investigation, exact and effective mutation screening is crucial for building focused therapies. The KRAS solutions Platform performs a pivotal function On this landscape by presenting comprehensive alternatives for KRAS mutation profiling and Investigation. KRAS mutations, present in approximately 95% o